These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 17429800

  • 21. [Toxicogenomics--a new paradigm of toxicology and birth of reverse toxicology].
    Hirabayashi Y, Inoue T.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2002; (120):39-52. PubMed ID: 12638183
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Toxicogenomics--the research of environment and health at gene expression level].
    Dai Y, Zheng Y.
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):413-5. PubMed ID: 14535116
    [Abstract] [Full Text] [Related]

  • 25. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P, Sasaki J.
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. How can toxicogenomics inform risk assessment?
    Oberemm A, Onyon L, Gundert-Remy U.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):592-8. PubMed ID: 15990130
    [Abstract] [Full Text] [Related]

  • 29. Genomics, proteomics and metabonomics in toxicology: hopefully not 'fashionomics'.
    Pognan F.
    Pharmacogenomics; 2004 Oct 01; 5(7):879-93. PubMed ID: 15469409
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.
    Leighton JK.
    Int J Toxicol; 2005 Oct 01; 24(3):153-5. PubMed ID: 16040567
    [Abstract] [Full Text] [Related]

  • 35. Predicting interactions from mechanistic information: can omic data validate theories?
    Borgert CJ.
    Toxicol Appl Pharmacol; 2007 Sep 01; 223(2):114-20. PubMed ID: 17306318
    [Abstract] [Full Text] [Related]

  • 36. Zebrafish in functional genomics and aquatic biomedicine.
    Aleström P, Holter JL, Nourizadeh-Lillabadi R.
    Trends Biotechnol; 2006 Jan 01; 24(1):15-21. PubMed ID: 16309768
    [Abstract] [Full Text] [Related]

  • 37. The use of toxicogenomic data in risk assessment: a regulatory perspective.
    Chan VS, Theilade MD.
    Clin Toxicol (Phila); 2005 Jan 01; 43(2):121-6. PubMed ID: 15822767
    [Abstract] [Full Text] [Related]

  • 38. Gels and more gels: probing toxicity.
    Witzmann FA, Bai F, Hong SM, Liu S, Pedrick N, Ringham H, Tan J.
    Curr Opin Mol Ther; 2004 Dec 01; 6(6):608-15. PubMed ID: 15663325
    [Abstract] [Full Text] [Related]

  • 39. The state-of-the-art in predictive toxicogenomics.
    Fielden MR, Kolaja KL.
    Curr Opin Drug Discov Devel; 2006 Jan 01; 9(1):84-91. PubMed ID: 16445120
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.